Related Experiment Video

Updated: Aug 23, 2026

Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria
11:32

Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria

Published on: February 23, 2014

Impact of PCV7 on invasive pneumococcal disease among children younger than 5 years: a population-based study

Revathi R Ramani1, William N Hall, Matthew Boulton

  • 1Bureau of Epidemiology, Michigan Department of Community Health, 3423 N Martin Luther King Blvd, Lansing, MI 48909, USA.

American Journal of Public Health
|July 14, 2004
PubMed

Insights

The heptavalent pneumococcal conjugate vaccine (PCV7) significantly lowered invasive pneumococcal disease hospitalizations in Michigan infants. Faster PCV7 vaccine uptake in younger children correlated with these reduced rates.

Area of Science:

  • Pediatrics
  • Vaccinology
  • Epidemiology

Background:

  • Invasive pneumococcal disease (IPD) poses a significant health risk to young children.
  • The heptavalent pneumococcal conjugate vaccine (PCV7) was introduced to prevent IPD.

Purpose of the Study:

  • To evaluate the impact of PCV7 introduction on IPD hospital discharge rates.
  • To assess IPD trends in children younger than 5 years in Michigan.

Main Methods:

  • Retrospective analysis of hospital discharge data.
  • Comparison of IPD rates before and after PCV7 introduction.
  • Correlation analysis between vaccine uptake and disease rates.

Main Results:

  • A significant decrease in IPD hospital discharge rates was observed in children younger than 1 year after PCV7 introduction.
  • This reduction correlated with the rapid uptake of PCV7 in this age group.
  • No significant changes in IPD discharge rates were noted for other age groups, suggesting slower PCV7 uptake.

Conclusions:

  • PCV7 effectively reduced IPD hospitalizations among infants in Michigan.
  • Vaccine uptake rates are critical for achieving population-level impact.
  • Targeted vaccination strategies may be needed to ensure equitable protection across all age groups.

More Related Videos

Experimental Human Pneumococcal Carriage07:47

Experimental Human Pneumococcal Carriage

Published on: February 15, 2013

Constructing Mutants in Serotype 1 Streptococcus pneumoniae strain 519/4306:06

Constructing Mutants in Serotype 1 Streptococcus pneumoniae strain 519/43

Published on: September 11, 2020

Related Concept Videos

Pneumonia V: Nursing management and Prevention01:30

Pneumonia V: Nursing management and Prevention

Nursing management of pneumonia involves promoting airway patency, facilitating rest and conserving energy, encouraging fluid intake, maintaining nutrition, and educating patients.
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed.
Respiratory Syncytial Virus Disease01:29

Respiratory Syncytial Virus Disease

Human respiratory syncytial virus (RSV) is a widespread pathogen that primarily targets infants and young children but also poses a serious health risk to elderly and immunocompromised individuals. Belonging to the Pneumoviridae family, RSV is a negative-sense, single-stranded RNA virus within the Pneumovirus genus. Its global health burden is significant, with millions of cases annually resulting in hospitalizations and mortality, particularly in resource-limited settings. Although most...
Streptococcal Pharyngitis01:27

Streptococcal Pharyngitis

Streptococcal pharyngitis, commonly known as “strep throat,” is an acute infection of the oropharyngeal tissues caused by the Gram‑positive Group A Streptococcus (Streptococcus pyogenes). Transmission occurs primarily through respiratory droplets expelled during coughing, sneezing, or talking.Mechanisms of Host Entry and Immune EvasionUpon entering the host, S. pyogenes adheres to the mucosal epithelial cells of the pharynx via surface proteins, notably lipoteichoic acid and the antiphagocytic...
Pneumonia I: Introduction01:29

Pneumonia I: Introduction

Pneumonia is an infection of the lower respiratory tract that leads to inflammation of the lung parenchyma, often resulting in the accumulation of inflammatory exudate in the alveoli and airways. Unlike the watery, low-protein fluid exudate in pulmonary edema, the exudate in this case is a thick fluid rich in immune cells, proteins, and debris produced during infection and inflammation.This impairs gas exchange and can lead to consolidation of lung tissue. The infection may be caused by a...
Pneumonia I: Introduction01:30

Pneumonia I: Introduction

Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Pneumonia II: Pathophysiology01:29

Pneumonia II: Pathophysiology

The pathophysiology of pneumonia involves the following steps: